Skip to search formSkip to main contentSkip to account menu

MBT-0206

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
3079 Background: MBT-0206 is a highly innovative anti-neovascular cytostatic compound designed to target and destroy newly formed… 
2004
2004
3163 Background: MBT-0206 is a highly innovative anti-neovascular cytostatic compound designed to target and destroy newly formed… 
2004
2004
3163 Background: MBT-0206 is a highly innovative anti-neovascular cytostatic compound designed to target and destroy newly formed… 
2004
2004
Background: Systemically administrated cationic lipid complexes accumulate selectively in angiogenic tumor endothelium. The… 
2004
2004
In the current study we investigated the anti-cancer potential of a combination therapy of MBT-0206 with the standard… 
2004
2004
1310 Systemically administrated cationic lipid complexes accumulate selectively in angiogenic tumor endothelium1,2. The…